AMPH
AMPH
US03209R1032
Amphastar Pharmaceuticals, Inc.
Loading chart...

Valuation & History

Quarterly trend of key valuation metrics

Metric
Current (TTM) TTM Baseline
Q2 '26 30.06.2026
Q1 '26 31.03.2026
Q4 '25 31.12.2025
Market & Enterprise Value
Market Cap
1.13B EUR
858.3M EUR
874.44M EUR
1.22B EUR
Enterprise Value
1.5B EUR
1.32B EUR
1.39B EUR
1.71B EUR
Valuation Multiples
Trailing P/E
15.75x
10.93x
11.04x
16.79x
Forward P/E
8.37x
--
--
--
Price to Sales
1.55x
1.18x
1.21x
2.23x
Price to Book
1.47x
1.12x
1.13x
1.55x
EV/Revenue
2.05x
1.81x
1.93x
3.11x
EV/EBITDA
7.69x
6.86x
7.2x
10.68x
Price to FCF (P/FCF)
4.92x
5.61x
6.58x
12.92x
EV/FCF
6.5x
8.65x
10.46x
18.06x
FCF Yield
20.32%
17.81%
15.2%
7.74%
ende